0001417827-15-000001.txt : 20150217 0001417827-15-000001.hdr.sgml : 20150216 20150217160852 ACCESSION NUMBER: 0001417827-15-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150217 DATE AS OF CHANGE: 20150217 EFFECTIVENESS DATE: 20150217 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Miragen Therapeutics Inc CENTRAL INDEX KEY: 0001417827 IRS NUMBER: 204362468 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-234182 FILM NUMBER: 15622356 BUSINESS ADDRESS: STREET 1: 6200 LOOKOUT ROAD CITY: Boulder STATE: CO ZIP: 80301 BUSINESS PHONE: (303) 531-5952 MAIL ADDRESS: STREET 1: 6200 LOOKOUT ROAD CITY: Boulder STATE: CO ZIP: 80301 D 1 primary_doc.xml X0707 D LIVE 0001417827 Miragen Therapeutics Inc 6200 LOOKOUT ROAD Boulder CO COLORADO 80301 (303) 531-5952 DELAWARE 358th Shelf Corporation None Corporation true William S. Marshall 6200 Lookout Road Boulder CO COLORADO 80301 Executive Officer Director Marvin Caruthers 6200 Lookout Road Boulder CO COLORADO 80301 Director Kyle Lefkoff 6200 Lookout Road Boulder CO COLORADO 80301 Director Bruce Booth 6200 Lookout Road Boulder CO COLORADO 80301 Executive Officer Director Thomas Hughes 6200 Lookout Road Boulder CO COLORADO 80301 Director John Creecy 6200 Lookout Road Boulder CO COLORADO 80301 Director Jason A Leverone 6200 Lookout Road Boulder CO COLORADO 80301 Executive Officer Christopher J Morl 6200 Lookout Road Boulder CO COLORADO 80301 Executive Officer David Rodman 6200 Lookout Road Boulder CO COLORADO 80301 Executive Officer Biotechnology Decline to Disclose 06b false 2015-02-03 true true Convertible notes which are convertible into equity securities of the Issuer. false 0 20000000 8499962 11500038 false 29 0 0 0 false Miragen Therapeutics Inc /s/ Jason A. Leverone Jason Leverone Chief Financial Officer 2015-02-17